Lv1
40 积分 2025-12-29 加入
Zanidatamab: First Approval
5天前
已完结
Molecular Testing and Targeted Therapies in Hepatobiliary Cancers: A Review
27天前
已完结
Optimizing outcomes and personalizing care with targeted agents in advanced cholangiocarcinoma
1个月前
已完结
Matching genomic molecular aberrations with molecular targeted agents: Are biliary tract cancers an ideal playground?
1个月前
已完结
Second-line therapies in advanced biliary tract cancers
1个月前
已完结
Molecular-based targeted therapies in patients with hepatocellular carcinoma and hepato-cholangiocarcinoma refractory to atezolizumab/bevacizumab
1个月前
已完结
Fibrolamellar hepatocellular carcinoma presenting with Budd-Chiari syndrome, right atrial thrombus, and pulmonary emboli
1个月前
已完结
Current and emerging therapies for advanced biliary tract cancers
1个月前
已完结
Current and emerging therapies for advanced biliary tract cancers
1个月前
已完结
HER2-targeted therapies - a role beyond breast cancer
1个月前
已完结
皖公网安备34019202002308
